Market Overview

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)

43.17 +0.49 (1.15%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/13/18BerenbergInitiates Coverage OnBuy55.0
11/19/18Credit SuisseMaintainsOutperform61.0
8/07/18Credit SuisseMaintainsOutperform56.0
3/20/18NeedhamUpgradesBuy
2/27/18CitigroupMaintainsBuy55.0
1/17/18Credit SuisseInitiates Coverage OnOutperform44.0
1/03/18Wells FargoUpgradesOutperform
7/12/17CitigroupMaintainsBuy37.0
6/27/17CitigroupInitiates Coverage OnBuy23.0
6/15/17Cantor FitzgeraldInitiates Coverage OnOverweight4.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter